Startseite Kongressberichte & Archiv St. Gallen International Gastrointestinal Cancer Conference Primary Therapy of Early GI Cancers - Session 2: Treatment of Oesophago-Gastric Cancer: Setting the Stage – Who Benefits from Multimodal Therapy

Session 2: Treatment of Oesophago-Gastric Cancer: Setting the Stage – Who Benefits from Multimodal Therapy

Chairs: Michel Ducreux (France), Paul M. Schneider (Switzerland)

  • Magnus Nilsson, Sweden: Which tumours need more treatment than just surgery? 
  • Angela Riddell, UK: What imaging is needed to select patients for neoadjuvant treatment & where are the limitations?
  • Marcel Verheij, The Netherlands: Patterns of recurrence to guide selection of multi-modal treatment?